Acurx Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Acurx Pharmaceuticals patents 7 in total

Status Patent
Application
Utility: DNA Polymerase IIIC Inhibitors and Use Thereof External link
Filling date: 26 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: Deuterium-Substituted 7-Substituted-2-(Benzylamino)-6-Ozopurine Compounds and Uses Thereof External link
Filling date: 26 Sep 2025 Issue date: 27 Jan 2022
Grant
Utility: DNA polymerase IIIC inhibitors and use thereof External link
Filling date: 26 Sep 2025 Issue date: 11 May 2021
Grant
Utility: DNA polymerase IIIC inhibitors and use thereof External link
Filling date: 26 Sep 2025 Issue date: 17 Nov 2020
Application
Utility: DNA Polymerase IIIC Inhibitors and Use Thereof External link
Filling date: 26 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: DNA Polymerase IIIC Inhibitors and Use Thereof External link
Filling date: 26 Sep 2025 Issue date: 1 Oct 2020
Grant
Utility: DNA polymerase IIIC inhibitors and use thereof External link
Filling date: 26 Sep 2025 Issue date: 28 Jul 2020

Showing 1 to 7 of 7 patents.